Synergistic Induction of Oxidative and Endoplasmic Reticulum Stress by Tempol and ML210 Combination Therapy in B16F10 Melanoma Cells
International Journal of Molecular Sciences · 2026
DOI: 10.3390/ijms27062675 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2026. Verfasst von Ebru Çelik und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Siirt Training and Research Hospital, Siirt 56000, Türkiye. Hauptthemen laut MEDLINE: Cyclic N-Oxides, Oxidative Stress, Endoplasmic Reticulum Stress, Melanoma, Experimental. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Cukurova University Research Fund.
Abstract (Originalsprache)
Given the challenges in treating metastatic melanomas, there is a growing need for novel and effective therapeutic strategies. This study aimed to understand molecular mechanisms underlying synergistic effects of a Tempol and ML210 combination in B16F10 murine melanoma cells and to evaluate its therapeutic potential. We hypothesized that this combination would synergistically induce cell death by increasing oxidative stress and triggering ER stress. B16F10 melanoma cells were treated with Tempol and ML210 alone or in combination for 48 h. Cell viability was determined using MTT assay. Oxidative stress was evaluated by measuring Total Antioxidant Status (TAS), Total Oxidant Status (TOS), and intracellular H2O2 levels. Apoptotic markers (caspase-3, Bax, Bcl-2) and ER stress proteins (GRP78, GADD153, IRE1α, ATF6) were quantified by ELISA. Combination treatment significantly inhibited cell proliferation compared to monotherapies. Molecular analyses revealed that combination caused depletion of TAS and increase in TOS and intracellular H2O2 levels. Furthermore, combination treatment synergistically upregulated ER stress markers and pro-apoptotic proteins while significantly suppressing anti-apoptotic Bcl-2 expression. In conclusion, the combination of Tempol and ML210 synergistically induces cell death in B16F10 melanoma cells by disrupting redox balance and activating ER stress-mediated apoptosis. These findings suggest a potential strategy for melanoma treatment that warrants further in vivo investigation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Dermatology, Siirt Training and Research Hospital, Siirt 56000, Türkiye.
- Department of Medical Biology, Faculty of Medicine, Cukurova University, Adana 01330, Türkiye.
- Department of Plastic, Reconstructive and Aesthetic Surgery, Faculty of Medicine, Cukurova University, Adana 01330, Türkiye.
- Deparment of Pharmacology, Faculty of Medicine, Cukurova University, Adana 01330, Türkiye.
ORCID-Profile: Ebru Çelik, Percin Pazarci, Ömer Kokaçya
Förderung
- Cukurova University Research Fund
Zitieren
APA
Çelik, E., Pazarci, P., Kokaçya, Ö., & Kaplan, H. M. (2026). Synergistic Induction of Oxidative and Endoplasmic Reticulum Stress by Tempol and ML210 Combination Therapy in B16F10 Melanoma Cells. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms27062675
Vancouver
Çelik E, Pazarci P, Kokaçya Ö, Kaplan HM. Synergistic Induction of Oxidative and Endoplasmic Reticulum Stress by Tempol and ML210 Combination Therapy in B16F10 Melanoma Cells. International Journal of Molecular Sciences. 2026. doi:10.3390/ijms27062675
BibTeX
@article{elik2026,
author = {Çelik, Ebru and Pazarci, Percin and Kokaçya, Ömer and Kaplan, Halil Mahir},
title = {Synergistic Induction of Oxidative and Endoplasmic Reticulum Stress by Tempol and ML210 Combination Therapy in B16F10 Melanoma Cells},
journal = {International Journal of Molecular Sciences},
year = {2026},
doi = {10.3390/ijms27062675}
}
EUVIMED